Elanco director granted stock awards as compensation

Ma Stacey reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Ma Stacey reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc director Stacey Ma received equity awards in the form of company stock. On May 21, 2026, she was granted 12,196 shares of common stock as deferred stock units and 4,678 shares as restricted stock units, both described as annual equity awards for non-employee directors. These are compensation-related grants at no cash purchase price, not open-market stock purchases or sales.

Insider Trade Summary

Grant/Award: 16,874 shares

Grant/Award 2 txns

Insider Ma Stacey

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,678	$0.00	$0.00
Grant/Award	Common Stock	12,196	$0.00	$0.00

Holdings After Transaction: Common Stock — 29,727 shares (Direct)

Footnotes (2)

1. F1. Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.
2. F2. Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Key Figures

Deferred stock unit grant: 12,196 shares Restricted stock unit grant: 4,678 shares Direct holdings after one grant: 29,727 shares +2 more

5 metrics

Deferred stock unit grant 12,196 shares Grant of deferred stock units on May 21, 2026

Restricted stock unit grant 4,678 shares Grant of restricted stock units on May 21, 2026

Direct holdings after one grant 29,727 shares Common stock directly held following one acquisition entry

Direct holdings after other grant 17,531 shares Common stock directly held following the second acquisition entry

Acquisition transactions 2 grants Two compensation-related acquisitions coded as “A”

Key Terms

deferred stock units, restricted stock units, non-employee members of the Issuer's Board of Directors

3 terms

deferred stock units financial

"Grant of deferred stock units as a pro-rated annual equity award"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

restricted stock units financial

"Grant of restricted stock units as an annual equity award"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

non-employee members of the Issuer's Board of Directors financial

"annual equity award to each of the non-employee members of the Issuer's Board of Directors"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elanco (ELAN) director Stacey Ma report in this Form 4?

Stacey Ma reported receiving equity awards of Elanco common stock as director compensation. The filing shows grants of deferred stock units and restricted stock units, both structured as annual awards for non-employee members of the company’s Board of Directors, with no open-market stock purchases or sales.

How many Elanco (ELAN) shares were granted to Stacey Ma in this filing?

The filing shows two grants to Stacey Ma: 12,196 shares of common stock tied to deferred stock units and 4,678 shares tied to restricted stock units. Both awards are part of her annual equity compensation as a non-employee director on Elanco’s Board of Directors.

Were Stacey Ma’s Elanco (ELAN) transactions open-market buys or sells?

No, the Form 4 classifies both entries as acquisitions from grants, not open-market trades. The transaction code “A” and a zero price per share indicate these are equity awards granted as compensation, rather than discretionary stock purchases or sales in the public market.

What types of equity awards did Elanco (ELAN) grant to Stacey Ma?

Stacey Ma received deferred stock units and restricted stock units linked to Elanco common stock. Footnotes describe one grant as a pro-rated annual equity award of deferred stock units, and the other as an annual equity award of restricted stock units for non-employee Board members.

How did these equity grants affect Stacey Ma’s Elanco (ELAN) share holdings?

The Form 4 indicates her direct holdings after one grant were 29,727 shares, and after the other grant 17,531 shares, reflecting different award lines. Together, the filing shows an increase in her equity-based position through compensation awards, with no corresponding disposals or sales reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 04:43 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ma Stacey

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/21/2026		A		4,678(1)	A	$0	17,531	D
Common Stock	05/21/2026		A		12,196(2)	A	$0	29,727	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.

2. Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Stacey Ma	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)